Botulinum toxin type A in the treatment of facial myotonia in Schwartz-Jampel syndrome

Muscle Nerve. 2017 Aug;56(2):E10-E11. doi: 10.1002/mus.25610. Epub 2017 Apr 8.

Authors

Igor Dórea Bandeira¹, João Gabriel Jagersbacher¹, Thiago Lima Barretto¹, Camilo Vieira Santos², Rita Lucena¹

Affiliations

¹ Department of Neuroscience and Mental Health, Medical School of Bahia, Federal University of Bahia, Praça XV de Novembro, s/n - Largo do Terreiro de Jesus, Salvador, Bahia, Brazil, 40025-010.
² Professor Edgard Santos University Hospital, Federal University of Bahia, Bahia, Brazil.

PMID: 28187499
DOI: 10.1002/mus.25610

No abstract available

Keywords: Schwartz-Jampel syndrome; botulinum toxin type A; facial myotonia; myotonia; rehabilitation.

Publication types

Case Reports

MeSH terms

Adolescent
Adult
Botulinum Toxins, Type A / therapeutic use*
Female
Humans
Myotonia / drug therapy*
Neuromuscular Agents / therapeutic use*
Osteochondrodysplasias / drug therapy*
Treatment Outcome

Substances

Neuromuscular Agents
Botulinum Toxins, Type A